Botulinum Toxin Type A 200U

BIOLOGICAL2 trials

Sponsors

Allergan, Lille Catholic University

Conditions

Joint DiseasesKneeMagnetic Resonance ImagingOveractive BladderTherapeutics

Phase 2

Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis

WithdrawnNCT03726788

Lille Catholic UniversityJoint Diseases, Knee, Magnetic Resonance Imaging +1

Start: 2019-09-30End: 2022-04-30Updated: 2025-09-10

Phase 3

A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

CompletedNCT00876447

AllerganOveractive Bladder

Start: 2009-01-01End: 2013-09-04Updated: 2019-05-01

Related Papers

Improvement in UI with OnabotulinumtoxinA Maintained over 4 Years in Patients with MS

MD Conference Express2014-06-01